Nutex Health Inc.

Johnson Fistel Investigates Nutex Health Following Short Report

Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Nutex Health Inc. (NASDAQ: NUTX) regarding possible violations of federal securities laws. Investors who purchased Nutex Health securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by the company and its executives.

If you suffered a loss on your investment and would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. The information provided will be held in strict confidence unless and until you authorize us to disclose it.

Name(Required)

First Last

Email(Required)

Phone(Required)

Estimated Losses(Required)

Where did you see our press release?(Required)

If you selected 'Other' above, please specify below:(Required)

Would you like to receive future case and securities updates from Johnson Fistel, PLLP via email?(Required)

Yes

Would you like to receive information about Johnson Fistel, PLLP's free portfolio monitoring service?(Required)

Yes

By checking the box, I acknowledge that this form is not intended to and does not establish an attorney-client relationship between myself and Johnson Fistel, PLLP, and that submission to or receipt of information from the firm or one of its attorneys via this form, website, email, or telephone does not create an attorney-client relationship.(Required)

I Agree

For more information, contact James Baker at (619) 814-4471, jimb@johnsonfistel.com or fjohnson@johnsonfistel.com.

On July 22, 2025, Blue Orca Capital published a short report raising concerns about Nutex Health’s recent 20-fold share price surge. The report alleges that the company’s growth was artificially driven by a third-party arbitration vendor, HaloMD—a consultancy linked to a former reality television contestant—which facilitated inflated out-of-network billing awards. According to Blue Orca, multiple federal lawsuits now allege that HaloMD orchestrated a fraudulent and racketeering scheme that siphoned millions from insurers, casting doubt on the legitimacy of Nutex’s reported revenue increases. While Nutex has not yet been named in any lawsuits, the report warns that insurers may pursue reimbursement or legal action against the company. Blue Orca contends that if the revenue benefits from HaloMD’s billing practices cease, Nutex’s financial performance could collapse, potentially returning its stock to penny-stock levels.

Nutex Health Inc.

Johnson Fistel Investigates Nutex Health Following Short Report

California

New York

Georgia

Colorado

Idaho